Drug for Rare Genetic Disorder Moves from FDA Priority to Rejection in Four Months

() -- The U.S. Food and Drug Administration's rejection of Disc Medicine In… Read more » Drug for Rare Genetic Disorder Moves from FDA Priority to Rejection in Four Months